Human Research Ethics Committee approval received for Phase II trial of R327 for acute bacterial skin and skin structure infections (ABSSSI), including diabetic foot and wound infections New site ...
Stockhead on MSN
No more tears as Recce takes on antibiotic superbug crisis
Recce is developing a new class of antibiotics to tackle drug-resistant superbugs almost a century after the development of ...
Broad patent coverage spans manufacturing, multiple infection types and flexible delivery methods Strengthens exposure to a major antibiotic market as Recce targets global superbug opportunity Special ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results